Skip to main content
. Author manuscript; available in PMC: 2024 Mar 20.
Published in final edited form as: Nat Med. 2022 Jun 23;28(8):1581–1589. doi: 10.1038/s41591-022-01856-6

Table 1 |.

Baseline characteristics and sequencing performed for the analytical cohort (n = 345)

Variable
Age at diagnosis (years), median (range) 12 (0–27.5)
Age at enrollment (years), median (range) 13 (0.2–28.8)
Sex, n (%)
 Female 151 (44)
 Male 194 (56)
Race, n (%)
 White 244 (71)
 Black or African-American 25 (7)
 Asian 14 (4)
 More than one race 29 (8)
 Other 33 (10)
Ethnicity, n (%)
 Hispanic or Latino 32 (9)
 Non-Hispanic 275 (80)
 Unknown 38 (11)
Cancer diagnosis, n (%)
 Osteosarcoma 64 (19)
 Rhabdomyosarcoma 46 (13)
 Ewing sarcoma 44 (13)
 Other sarcoma 70 (20)
 Renal tumor 29 (8)
 Neuroblastoma 28 (8)
 Liver tumor 13 (4)
 Carcinoma 19 (6)
 Other 32 (9)
Sequencing method, n (%)
 Targeted DNA NGS only 269 (78)
 Targeted DNA NGS + RNA NGS 32 (9)
 Targeted DNA NGS + whole transcriptome 26 (8)
 Targeted DNA NGS + RNA NGS + whole transcriptome 18 (5)